STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-08-23
Here’s whether Amgen Inc (AMGN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.69% over 10 days); strong 1-year return of +48.5%; 3-month momentum positive (+29.5%). Concerns: RSI 82 — overbought, elevated pullback risk. Currently 0.9% off its 52-week high. Score: +5/7.
AMGN is in a confirmed uptrend, trading above both its 50-day ($378.96) and 200-day ($352.83) moving averages. With an RSI of 81.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +48.5% compares to +20.5% for SPY (beat the market by 28.1%).
$10,000 invested 1 year ago→ $14,854 today
vs. S&P 500 (SPY) — same period beat market by 28.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($352.83)
✓Above 50-day MA ($378.96)
!RSI(14) neutral zone (30–70) — currently 81.9
✓Positive return (+48.5%)
✓Within 10% of period high (−0.9%)
Period Range $439.33
$269.77$443.20
RSI (14) 81.9
0 · OversoldOverbought · 100
Key Metrics
Price$439.33
Period Return+48.5%
Period High$443.20
Period Low$269.77
Drawdown−0.9%
MA-50$378.96
MA-200$352.83
RSI (14)81.9
Avg Volume (30d)2.6M
vs. SPYbeat by 28.1%
Return Rank#251 of 999
Trend Signals
Price is above the 200-day moving average ($352.83)
Price is above the 50-day moving average ($378.96)